(USD) | Dec 2023 | Q/Q |
---|---|---|
Revenue | -354.1MM | -291% |
Gross Profit | -181.1MM | -302% |
Cost Of Revenue | 103.5MM | +8% |
Operating Income | 163.1MM | -617% |
Operating Expenses | -344.2MM | -384% |
Net Income | 162.6MM | -593% |
R&D | - | - |
G&A | 85.8MM | +8% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
SAN DIEGO, April 09, 2024--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2024 results after the financial markets close on Thursday, May 2, 2024. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its first quarter 2024 financial and operating results.
When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase...
Don't give up on this healthcare stock too soon.
RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds released “The RiverPark/Next Century Growth Fund” Q4 2023 investor letter in partnership with Next Century Growth Investors, LLC. A copy of the same can be downloaded here. The fund returned 4.75% in the fourth quarter compared to a 12.75% return […]
Inari Medical (NARI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
One product in particular could juice the company's fundamentals, a pundit believes.
Tandem Diabetes Care (TNDM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Small cap stocks like those discussed below tend to receive much less attention than their large cap competitors. Shares, which boast a market capitalization between $250 million and $2 billion, remain relatively small. The largest stocks including Nvidia (NASDAQ:NVDA) and Microsoft (NASDAQ:MSFT) are valued into the trillions. It’s no surprise then that they receive the lion’s share of investor attention and capital. As a result, there are a lot of deals to be had among small-cap stocks. Investo
Next Century Growth Investors, LLC, an investment Management Company, released its “SMID Cap Growth Strategy” fourth-quarter investor letter. A copy of the same can be downloaded here. October had negative returns from the equity markets in the fourth quarter of 2023, but November and December saw a robust market rally that produced positive returns for […]
Product innovations and strategic progress bode well for Tandem Diabetes (TNDM).